SQY51
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SQY51, covering 2024-04-01 to 2024-04-01. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1/2a for Safety, PK and PD of SQY51 in Paediatric and Adult Patients Duchenne Muscular Dystrophy [Phase 1, Phase 2]